These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 33214842)
1. Novel Betulinic Acid-Nucleoside Hybrids with Potent Anti-HIV Activity. Wang Q; Li Y; Zheng L; Huang X; Wang Y; Chen CH; Cheng YY; Morris-Natschke SL; Lee KH ACS Med Chem Lett; 2020 Nov; 11(11):2290-2293. PubMed ID: 33214842 [TBL] [Abstract][Full Text] [Related]
2. Novel 2-indolinone thiazole hybrids as sunitinib analogues: Design, synthesis, and potent VEGFR-2 inhibition with potential anti-renal cancer activity. Mahmoud HK; Farghaly TA; Abdulwahab HG; Al-Qurashi NT; Shaaban MR Eur J Med Chem; 2020 Dec; 208():112752. PubMed ID: 32947227 [TBL] [Abstract][Full Text] [Related]
3. Targeting the hydrophobic channel of NNIBP: discovery of novel 1,2,3-triazole-derived diarylpyrimidines as novel HIV-1 NNRTIs with high potency against wild-type and K103N mutant virus. Zhou Z; Liu T; Wu G; Kang D; Fu Z; Wang Z; De Clercq E; Pannecouque C; Zhan P; Liu X Org Biomol Chem; 2019 Mar; 17(12):3202-3217. PubMed ID: 30839042 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of DAPY-DPEs hybrids as non-nucleoside inhibitors of HIV-1 reverse transcriptase. Wu HQ; Yao J; He QQ; Chen WX; Chen FE; Pannecouque C; De Clercq E; Daelemans D Bioorg Med Chem; 2015 Feb; 23(3):624-31. PubMed ID: 25537532 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of some novel 1,2,3-triazole hybrids of myrrhanone B isolated from Commiphora mukul gum resin: Identification of potent antiproliferative leads active against prostate cancer cells (PC-3). Madasu C; Karri S; Sangaraju R; Sistla R; Uppuluri MV Eur J Med Chem; 2020 Feb; 188():111974. PubMed ID: 31883489 [TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, molecular docking and cytotoxic evaluation of novel 2-furybenzimidazoles as VEGFR-2 inhibitors. Abdullaziz MA; Abdel-Mohsen HT; El Kerdawy AM; Ragab FAF; Ali MM; Abu-Bakr SM; Girgis AS; El Diwani HI Eur J Med Chem; 2017 Aug; 136():315-329. PubMed ID: 28505536 [TBL] [Abstract][Full Text] [Related]
7. Development of a pseudovirus assay and evaluation to screen natural products for inhibition of HIV-1 subtype C reverse transcriptase. Mavhandu LG; Cheng H; Bor YC; Tebit DM; Hammarskjold ML; Rekosh D; Bessong PO J Ethnopharmacol; 2020 Aug; 258():112931. PubMed ID: 32360797 [TBL] [Abstract][Full Text] [Related]
8. N-[2-(1-cyclohexenyl)ethyl]-N'-[2-(5-bromopyridyl)]-thiourea and N'-[2-(1-cyclohexenyl)ethyl]-N'-[2-(5-chloropyridyl)]-thiourea as potent inhibitors of multidrug-resistant human immunodeficiency virus-1. Uckun FM; Mao C; Pendergrass S; Maher D; Zhu D; Tuel-Ahlgren L; Venkatachalam TK Bioorg Med Chem Lett; 1999 Sep; 9(18):2721-6. PubMed ID: 10509923 [TBL] [Abstract][Full Text] [Related]
9. Anti-AIDS agents 88. Anti-HIV conjugates of betulin and betulinic acid with AZT prepared via click chemistry. Bori ID; Hung HY; Qian K; Chen CH; Morris-Natschke SL; Lee KH Tetrahedron Lett; 2012 Apr; 53(15):1987-1989. PubMed ID: 22711941 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and cytotoxic activity of nitric oxide-releasing isosteviol derivatives. Wang TT; Liu Y; Chen L Bioorg Med Chem Lett; 2014 May; 24(9):2202-5. PubMed ID: 24685545 [TBL] [Abstract][Full Text] [Related]
11. Betulinic Acid Decorated with Polar Groups and Blue Emitting BODIPY Dye: Synthesis, Cytotoxicity, Cell-Cycle Analysis and Anti-HIV Profiling. Kodr D; Stanková J; Rumlová M; Džubák P; Řehulka J; Zimmermann T; Křížová I; Gurská S; Hajdúch M; Drašar PB; Jurášek M Biomedicines; 2021 Aug; 9(9):. PubMed ID: 34572290 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and anti-HBV activity of carbocyclic nucleoside hybrids with salient features of entecavir and aristeromycin. Samunuri R; Toyama M; Pallaka RS; Neeladri S; Jha AK; Baba M; Bal C RSC Med Chem; 2020 May; 11(5):597-601. PubMed ID: 33479662 [TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of a new series of modified CH-diarylpyrimidines as drug-resistant HIV non-nucleoside reverse transcriptase inhibitors. Meng G; Liu Y; Zheng A; Chen F; Chen W; De Clercq E; Pannecouque C; Balzarini J Eur J Med Chem; 2014 Jul; 82():600-11. PubMed ID: 24952305 [TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and anti-HIV evaluation of 5-alkyl- 6-(benzo[d][1,3]dioxol-5-alkyl)-2-mercaptopyrimidin-4(3H)-ones as potent HIV-1 NNRTIs. Li YM; Luo RH; Yang LM; Huang SM; Li SY; Zheng YG; Ni DX; Cui YM; Zhang XJ; Li XL; Zhang RH; Tang E; Zhang HB; Zheng YT; He YP; Xiao WL Bioorg Chem; 2020 Sep; 102():104041. PubMed ID: 32683184 [TBL] [Abstract][Full Text] [Related]
15. Novel ciprofloxacin hybrids using biology oriented drug synthesis (BIODS) approach: Anticancer activity, effects on cell cycle profile, caspase-3 mediated apoptosis, topoisomerase II inhibition, and antibacterial activity. Kassab AE; Gedawy EM Eur J Med Chem; 2018 Apr; 150():403-418. PubMed ID: 29547830 [TBL] [Abstract][Full Text] [Related]
16. Anti-AIDS agents 73: structure-activity relationship study and asymmetric synthesis of 3-O-monomethylsuccinyl-betulinic acid derivatives. Qian K; Nakagawa-Goto K; Yu D; Morris-Natschke SL; Nitz TJ; Kilgore N; Allaway GP; Lee KH Bioorg Med Chem Lett; 2007 Dec; 17(23):6553-7. PubMed ID: 17935987 [TBL] [Abstract][Full Text] [Related]